Articles from Iterative Health

Iterative Health, a healthcare technology and services company advancing GI clinical research, and One GI®, a top physician-led management services organization (MSO) and portfolio company of Webster Equity Partners, today announced a strategic partnership to advance clinical research as a core ancillary service for OneGI’s community providers, while expanding access to innovative trials. The collaboration reinforces research as an integral offering in community-based gastroenterology (GI) care across a leading network of independent physician practices.

GI Alliance (GIA), a Cardinal Health company and the nation’s leading physician-led gastroenterology network, has formed a strategic partnership with Iterative Health, a healthcare technology and services company advancing GI clinical research. This collaboration aims to expand access to clinical trials across community-based practices. By integrating GIA’s established clinical research sites with the Iterative Health Site Network, the partnership creates a premier global research network focused on gastrointestinal and hepatological diseases.

Iterative Health, a healthcare technology and services company partnering with physicians to advance gastrointestinal care, will present five abstracts at the European Crohn’s & Colitis Organization (ECCO) meeting in Berlin, Germany, Feb. 19-22, 2025. These data demonstrate the unprecedented performance of Iterative Health’s AI-enabled Endoscopic Score (AI-ES) and extended Endoscopic Score (AI-ESe) to achieve a standardized and reproducible measure of disease severity and treatment response for ulcerative colitis (UC), and were conducted in collaboration with Eli Lilly and Company and leading academic researchers.

Iterative Health, a healthcare technology and services company partnering with physicians to advance gastrointestinal care, today announced that Unio Specialty Care, a rapidly growing physician practice and services platform, has partnered to deploy Iterative Health’s SKOUT AI technology at surgery centers across California to enhance colonoscopies for colorectal cancer screening.

Iterative Health, a technology and services company dedicated to advancing gastrointestinal care, will present new data at the American College of Gastroenterology 2024 Annual Meeting, co-authored with leading academic researchers and life science partners. The five abstracts highlight the opportunity for advanced machine learning (ML) algorithms to address shortcomings in the current approach to endoscopic assessment of inflammatory bowel disease (IBD) in clinical trials and routine care.

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today the results of new research unveiled at the American College of Gastroenterology (ACG) Annual Scientific Meeting. The five publications shared at the event capture Iterative Health’s research findings, which explore the use of Computer-Aided Detection (CADe) devices and artificial intelligence (AI) in improving clinical trial recruitment for inflammatory bowel disease. This research represents strides toward enhancing the detection of precursor adenomas and streamlining clinical trial recruitment processes in gastroenterology, ultimately bringing us closer to a future of advancing patient care in the field. The publications include:

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Allied Digestive Health (ADH), a leading gastroenterology practice, to bring Clinical Trial Optimization to ADH’s research centers across New Jersey and New York to aid in the recruitment of patients for inflammatory bowel disease clinical trials.

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, and Provation, the premier software and SaaS provider of clinical productivity and workflow automation solutions and a wholly-owned operating company of Fortive Corporation (NYSE: FTV), announced today the upcoming commercial availability of SKOUT, real-time artificial intelligence for polyp detection, in the second quarter of 2023. SKOUT is indicated as a computer-aided detection tool to assist qualified and trained endoscopists in identifying potential colorectal polyps during colonoscopy examinations in adult patients undergoing colorectal cancer screening or surveillance.

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Florida Research Institute (FRI), a leader in gastroenterology and hepatology research, to bring its AI-Recruitment (AIR) technology to the Florida region to standardize endoscopic scoring and give patients better access to more precise therapeutics by way of clinical trials. The implementation of AIR will aid in the recruitment of patients to clinical trials focused on advancing therapies for inflammatory bowel disease (IBD). The two organizations will help to democratize access to novel IBD therapeutics for all patients, regardless of where they receive care.

Built In today announced that Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, was honored in its 2023 Best Places To Work Awards. Specifically, the company earned a place on the list of Boston’s Best Midsize Places to Work. The annual awards program includes companies of all sizes, from startups to those in the enterprise, and honors both remote-first employers as well as companies in large tech markets across the U.S.

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Gastro Health, a national leading medical group specializing in digestive and liver health, to bring its AI Recruitment (AIR) technology to Gastro Health’s practices. This strategic partnership will lay the groundwork for future collaborations by using AIR to aid in the recruitment of patients for clinical trials in inflammatory bowel disease (IBD) and expanding Gastro Health’s clinical research capabilities.

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, today announced that it has been named one of CB Insights’ top 150 companies in Digital Health for 2022, the second year in a row in which it has made this list. The Digital Health 150 is CB Insights’ annual ranking of the 150 most promising digital health startups in the world. Iterative Health was recognized in the Computer-Aided Imaging category.

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has expanded its team with two new additions: Jeremy Freeman has joined the company as Senior Vice President of Technology, and Scott Lish has joined as Vice President of Sales.

Iterative Health, formerly known as Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, has announced a rebrand to reflect the company’s success in utilizing artificial intelligence (AI) to strengthen clinical research and augment clinical decision making within gastroenterology.